Literature DB >> 1362969

Richner-Hanhart syndrome (oculocutaneous tyrosinaemia, tyrosinaemia type II)

D G Paige1, P Clayton, A Bowron, J I Harper.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1362969      PMCID： PMC1293768          DOI： 10.1177/014107689208501216

Source DB:  PubMed          Journal:  J R Soc Med        ISSN： 0141-0768            Impact factor:   18.000


× No keyword cloud information.
  6 in total

1.  Tyrosinemia with plantar and palmar keratosis and keratitis.

Authors:  L A Goldsmith; E Kang; D C Bienfang; K Jimbow; P Gerald; H P Baden
Journal:  J Pediatr       Date:  1973-11       Impact factor: 4.406

2.  Richner-Hanhart syndrome (tyrosinaemia-II) (report of four cases without ocular involvement).

Authors:  A Rehák; M M Selim; G Yadav
Journal:  Br J Dermatol       Date:  1981-04       Impact factor: 9.302

3.  Outcome in tyrosinaemia type II.

Authors:  D G Barr; J M Kirk; S C Laing
Journal:  Arch Dis Child       Date:  1991-10       Impact factor: 3.791

4.  Successful dietary control of tyrosinemia II.

Authors:  H Machino; Y Miki; T Kawatsu; K Kida; H Matsuda
Journal:  J Am Acad Dermatol       Date:  1983-10       Impact factor: 11.527

5.  Dietary management of oculocutaneous tyrosinemia in an 11-year-old child.

Authors:  D Ney; C Bay; J A Schneider; D Kelts; W L Nyhan
Journal:  Am J Dis Child       Date:  1983-10

6.  Inherited and de novo deletion of the tyrosine aminotransferase gene locus at 16q22.1----q22.3 in a patient with tyrosinemia type II.

Authors:  E Natt; E M Westphal; S E Toth-Fejel; R E Magenis; N R Buist; R Rettenmeier; G Scherer
Journal:  Hum Genet       Date:  1987-12       Impact factor: 4.132
  6 in total
  2 in total

1.  Effect of acute and chronic administration of L-tyrosine on nerve growth factor levels in rat brain.

Authors:  Gabriela K Ferreira; Isabela C Jeremias; Giselli Scaini; Milena Carvalho-Silva; Lara M Gomes; Camila B Furlanetto; Meline O Morais; Patrícia F Schuck; Gustavo C Ferreira; Emilio L Streck
Journal:  Neurochem Res       Date:  2013-05-21       Impact factor: 3.996

2.  A child with dendritiform eye lesions and developmental delay.

Authors:  Vasiliki Gliagias; Ksenia Denisova; Joann J Kang
Journal:  Am J Ophthalmol Case Rep       Date:  2022-09-06
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.